greeksoup/ stock research

Nordson (NDSN) FY2025 results: revenue $2.8 billion, up 3.8% on the year

Nordson Corp. (NDSN) reported revenue of $2.8 billion for fiscal 2025, the year ended 31 October 2025, up 3.8% on the year before. Net income was $484 million, up 3.7%, and diluted earnings per share $8.51. The figures are the company's own, from the 10-K it filed with the SEC on 17 December 2025.

Revenue
$2.8 billion
+3.8% on the year
FY2018FY2025
Operating margin
25.5%
25.1% a year earlier
FY2018FY2025
Net income
$484 million
+3.7% on the year
FY2018FY2025
Diluted EPS
$8.51
+4.9% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The year in brief

What management said about the year

Guidance figures: 4 new.

  • Fourth-quarter sales rose 1%: Sales were $752 million, up 1% from $744 million. Organic sales decreased 1% in the quarter.
  • Quarterly adjusted EPS up 9%: GAAP diluted EPS was $2.69 against $2.12 a year earlier. Adjusted EPS was $3.03 against $2.78.
  • Record full-year sales: Full-year sales reached $2.8 billion, up 4%. Acquisitions added 6% and organic volume declined 3%.
  • Medical and Fluid led growth: Sales of $220 million rose 10%, with 7% organic growth in all product lines. EBITDA margin was 40%, up 380 basis points.
  • Sales range tied to order book: Fiscal 2026 sales expectations rest on order entry, backlog, current exchange rates and anticipated end market expectations.
Read the Q4 FY2025 earnings call summary

From this 10-K

Nordson engineers, makes and markets products for precision dispensing, applying and controlling adhesives, coatings, polymers, sealants, biomaterials and other fluids, for testing and inspecting quality, and for treating and curing surfaces and medical products such as catheters, cannulas, medical balloons and tubing. It serves consumer non-durable, consumer durable and technology end markets including packaging, electronics, medical, appliances, energy, transportation, precision agriculture, building and construction and general product assembly and finishing. It was incorporated in Ohio in 1954, is headquartered in Westlake, Ohio, markets through direct operations in more than 35 countries, and generated approximately 67 percent of what it took in outside the United States in 2025. Equipment ranges from single-use components through manual stand-alone units to microprocessor-based automated systems for high-speed production lines, sold mainly through a direct sales force with distributors and sales representatives; no single customer was ten percent or more of sales in 2025.

Nordson Corp., the 10-K for 2025

Nordson engineers, makes and markets products for precision dispensing, applying and controlling adhesives, coatings, polymers, sealants, biomaterials and other fluids, for testing and inspecting quality, and for treating and curing surfaces and medical products such as catheters, cannulas, medical balloons and tubing. It serves consumer non-durable, consumer durable and technology end markets including packaging, electronics, medical, appliances, energy, transportation, precision agriculture, building and construction and general product assembly and finishing. It was incorporated in Ohio in 1954, is headquartered in Westlake, Ohio, markets through direct operations in more than 35 countries, and generated approximately 67 percent of what it took in outside the United States in 2025. Equipment ranges from single-use components through manual stand-alone units to microprocessor-based automated systems for high-speed production lines, sold mainly through a direct sales force with distributors and sales representatives; no single customer was ten percent or more of sales in 2025.

Industrial Precision Solutions

The segment sells dispensing and material processing technology into consumer durables, non-durables, industrial, agriculture and automotive markets. Industrial coatings covers automated and manual dispensing for cold materials, container coating, liquid finishing and powder coating, plus ultraviolet equipment for curing and drying, aimed at beverage containers and food cans, batteries, appliances, automotive, building and construction, electronics and medical. Nonwovens covers dispensing, coating and laminating systems that apply adhesives, lotions, liquids and fibres to disposable products and continuous roll goods, for adult incontinence products, nappies, hygiene products and surgical drapes, gowns and face masks. Packaging covers automated adhesive dispensing for rigid packaged goods in food and beverage, pharmaceutical and other consumer goods. Polymer processing supplies components and systems used in the thermoplastic and biopolymer melt stream in extrusion, injection moulding, compounding, polymerisation and recycling. Precision agriculture supplies spraying products including nozzles, pumps and filters, smart components that measure and control the flow, quantity and location of dispensed fluid, and control systems, supported by software and data. Product assembly covers dispensing, coating and laminating for plastic, metal and wood products, paper and paperboard converting and continuous roll goods.

Medical and Fluid Solutions

The segment supplies components and device products for medical, life science, high-tech industrial and other markets. Engineered fluid solutions covers precision manual and semi-automated dispensers and engineered single-use plastic moulded syringes, cartridges, tips and fluid connection components used in medical and industrial production and in applying adhesives, sealants and lubricants. Medical interventional solutions covers minimally invasive surgical work, with engineered shafts and interventional delivery systems, medical tubing, balloons, balloon inflators, nitinol devices, cardiovascular cannula and biomaterial delivery, aimed at cardiovascular, structural heart, neurovascular and gastroenterology. Medical fluid components covers single-use plastic components including drug delivery and needle-free infusion valves and fluid transfer components, for drug infusion, intravenous delivery, patient care, surgical and biopharma use. Surgical solutions covers microplegia myocardial protection devices and related consumables used in cardiac surgery.

Advanced Technology Solutions

The segment folds the company's technologies into successive stages of a customer's production process, covering surface treatment, precisely controlled dispensing and pre- and post-dispense test and inspection, and serves mainly semiconductor and electronics customers. Electronics dispense systems covers automated dispensing for high-speed application of attachment, protection and coating fluids, with gas plasma systems that clean and condition surfaces beforehand, sold across the electronics supply chain producing semiconductors, printed circuit board assemblies and components. Test and inspection covers destructive and non-destructive testing such as bond testers and automated optical, acoustic microscopy and x-ray inspection systems, plus in-line measurement sensors, gauges and analysers using near-infrared, laser, x-ray, optical and nucleonic technologies, for semiconductor packaging, printed circuit boards, flexible circuits, consumer electronics, film extrusion, cable and tubing and energy storage.

Making it, and competing

Production covers machining, moulding and assembly, with specially designed parts made in-house and components assembled into finished equipment, many of them standard modules usable in more than one product. Principal manufacturing sits across fifteen American states and in China, Bulgaria, Germany, Ireland, India, Israel, Italy, Mexico, the Netherlands and the United Kingdom. Principal materials are sheet metal, fabricated metal parts, bar stock, castings, forgings, tubing, plastic parts and pellets, plus bought-in electrical and electronic components, fluid hoses, packings and seals; most come from multiple sources, though costs can move with raw material prices, tariffs particularly on imports from China, and disruptions in availability. It holds more than 2,100 granted and pending patents and more than 1,000 trademarks, valuable in aggregate, while attributing its competitive advantage largely to the technical, marketing and sales capability of its employees, so it treats no single right as material. Sales are historically highest in the second half of the fiscal year and lowest in the first quarter, driven by the timing of customers' capital spending programmes and customer holiday shutdowns. It competes with many large, well-established manufacturers and service providers and against alternative bonding, sealing, finishing, coating, processing, testing, inspecting and fluid control techniques, on pricing, product quality and service. At 31 October 2025 it had approximately 8,000 employees worldwide.

From Nordson's annual report on Form 10-K for the year ended 31 October 2025. The filing

Written from the 10-K filed 17 December 2025: read the full 10-K.

The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025

Income statement (profit and loss)

$ millionFY2025FY2024FY2023On the yearLast 8 years
Revenue2,7922,6902,629+3.8%
Cost of revenue1,2521,2041,203+4.0%
Gross profit1,5401,4861,425+3.6%
Gross margin55.2%55.2%54.2%
Research and development68.265.071.4+5.0%
Selling, general and administrative816812753+0.4%
Operating income712674673+5.6%
Operating margin25.5%25.1%25.6%
Interest expense10488.959.5+17.1%
Pre-tax income598585615+2.1%
Income tax113118128-4.2%
Effective tax rate18.9%20.2%20.8%
Net income484467487+3.7%
Net margin17.4%17.4%18.5%
Diluted EPS$8.51$8.11$8.46+4.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2025FY2024FY2023On the yearLast 8 years
Operating cash flow719556641+29.3%
Capital expenditure58.164.434.6-9.9%
Free cash flow661492607+34.4%
Free cash flow margin23.7%18.3%23.1%
Cash from investing-26.7-844-1,437
Cash from financing-706294751
Depreciation and amortisation79.377.059.7+3.0%
Share-based compensation18.919.022.7-0.1%
Buybacks30633.389.7+818.9%
Dividends paid179161150+10.9%
Dividend per share$3.16$2.82$2.63+12.1%
Diluted shares, weighted57m58m58m-1.2%
Shares outstanding at period end56m57m57m-2.2%

Balance sheet

$ millionFY2025FY2024FY2023On the yearLast 8 years
Shareholders' equity3,0442,9322,598+3.8%
Debt1,9962,1871,732-8.7%
Operating lease liabilities64.580.892.4-20.3%
Finance lease liabilities8.412.111.7-30.8%
Other liabilities805789818+2.0%
Total liabilities and equity5,9186,0015,252-1.4%
Fixed assets517545393-5.1%
Goodwill3,3053,2812,784+0.7%
Intangible assets682741673-8.0%
Cash and equivalents108116116-6.5%
Receivables588595591-1.1%
Inventory445477455-6.7%
Other assets273247241+10.6%
Total assets5,9186,0015,252-1.4%

10-K for the year ended 31 October 2025, filed 17 December 2025: the filing.